Congress Takes Action to Reverse the Nation’s Diabetes Epidemic

International Endocrinology Association Commends Bi-Partisan Passage of National Clinical Care Commission Act in House of Representatives

Tuesday, November 15, 2016 7:58 am EST

Dateline:

WASHINGTON
"Our appreciation goes to Representatives Pete Olson and Dave Loebsack, and their House colleagues who supported this bill, and to the many other diabetes organizations across our nation that joined AACE in advocating for its passage."

WASHINGTON--(BUSINESS WIRE)--The American Association of Clinical Endocrinologists (AACE) applauds the passage of the National Clinical Care Commission Act (H.R. 1192) yesterday in the U.S. House of Representatives as a crucial step towards improving the care and well-being of almost 30 million Americans suffering from diabetes and its consequences.

H.R. 1192, which has been a long-standing legislative priority for AACE, establishes a public/private commission consisting of the country’s foremost diabetes researchers, specialists, clinical healthcare professionals and patient advocates who will collectively assess federal diabetes initiatives to identify redundant or ineffective activities and critical gaps, and recommend new approaches to address the disease to the Secretary of Health and Human Services and Congress. The commission will help streamline and leverage the substantial federal investment in diabetes research, policy and programs, which currently are spread across more than 35 federal agencies.

Since the bill was first introduced in the House during the 112th Congress, the prevalence of diabetes has continued to surge: According to the Centers for Disease Control and Prevention (CDC), diabetes afflicts one in every nine adult Americans, and an additional 86 million Americans have prediabetes. The total annual cost of diabetes in the U.S. is estimated at $245 billion.

“As long-time advocates and supporters of this legislation, we’re extraordinarily pleased that this bill is moving forward to the Senate for consideration,” said AACE President Dr. Pauline Camacho. “Our appreciation goes to Representatives Pete Olson and Dave Loebsack, and their House colleagues who supported this bill, and to the many other diabetes organizations across our nation that joined AACE in advocating for its passage.”

“We look forward to what will hopefully be quick consideration by the Senate to enact the National Clinical Care Commission Act this year. Congress should not pass up the opportunity to do something about diabetes and begin to reverse the devastating human and economic toll the disease imposes on our healthcare system,” added AACE President Elect Dr. Jonathan Leffert.

The Senate companion legislation is sponsored by Sen. Jeanne Shaheen (D-NH) and Sen. Susan Collins (R-ME) with 33 Senate co-sponsors.

To read the bill in its entirety, or to learn more about supporting the National Clinical Care Commission Act, visit: https://www.aace.com/article/220

About the American Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Diabetes, Endocrinology and Metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our site at www.aace.com .

Contact:

American Association of Clinical Endocrinologists (AACE)
Mary Green, 904-353-7878
mgreen@aace.com